Home
>
National Drug Code (NDC)
>
Xerese
Xerese - 0187-5104-01 - (Acyclovir and Hydrocortisone)
Drug Information of Xerese
| Product NDC: | 0187-5104 |
| Proprietary Name: | Xerese |
| Non Proprietary Name: | Acyclovir and Hydrocortisone |
| Active Ingredient(s): | 50; 10 mg/g; mg/g & nbsp; Acyclovir and Hydrocortisone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Xerese
| Product NDC: | 0187-5104 |
| Labeler Name: | Valeant Pharmaceuticals North America LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022436 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100715 |
Package Information of Xerese
| Package NDC: | 0187-5104-01 |
| Package Description: | 1 TUBE in 1 CARTON (0187-5104-01) > 5 g in 1 TUBE |
NDC Information of Xerese
| NDC Code | 0187-5104-01 |
| Proprietary Name | Xerese |
| Package Description | 1 TUBE in 1 CARTON (0187-5104-01) > 5 g in 1 TUBE |
| Product NDC | 0187-5104 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Acyclovir and Hydrocortisone |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20100715 |
| Marketing Category Name | NDA |
| Labeler Name | Valeant Pharmaceuticals North America LLC |
| Substance Name | ACYCLOVIR; HYDROCORTISONE |
| Strength Number | 50; 10 |
| Strength Unit | mg/g; mg/g |
| Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
